http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007136169-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01J1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82B3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate | 2006-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007136169-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SKIN DISEASES CAUSED BY MUSHROOMS AND YEAST |
| abstract | 1. A pharmaceutical composition comprising a therapeutically effective amount of sertaconazole or a pharmaceutically acceptable salt, solvate, isomer or mixtures thereof, and a therapeutically effective amount of at least one compound selected from the group consisting of hydrocortisone, a pharmaceutically acceptable hydrocortisone ester, an antibacterial quinolone compound, or mixtures thereof, optionally in combination with at least one pharmaceutically acceptable excipient or carrier, or mixtures thereof. ! 2. The composition according to claim 1, in which a therapeutically effective amount of sertaconazole or its pharmaceutically acceptable salt, MES, isomer or mixtures thereof is in the range from 0.1 to 10 wt.% By weight of the composition. ! 3. The composition according to claim 2, in which the therapeutically effective amount of sertaconazole or its pharmaceutically acceptable salt, solvate, isomer or mixtures is in the range from 0.2 to 8 wt.% By weight of the composition. ! 4. The composition according to claim 1, in which sertaconazole is selected from the group consisting of sertaconazole base, R-sertaconazole base, sertaconazole mononitrate and R-sertaconazole mononitrate. ! 5. The composition according to claim 4, in which R-sertaconazole base or R-sertaconazole mononitrate is present in an amount of from 0.3 to 5 wt.% By weight of the composition. ! 6. The composition according to claim 4, in which sertaconazole base or sertaconazole mononitrate is present in an amount of from 0.5 to 5 wt.% By weight of the composition. ! 7. The composition according to claim 1, in which the therapeutically effective amount of hydrocortisone or its pharmaceutically acceptable ester or mixtures thereof is in the range from 0.05 to 5 wt.% From � |
| priorityDate | 2005-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.